2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and OlderHealthy Volunteers; Human Metapneumovirus Immunization; Respiratory Syncytial Virus ImmunizationRecruitingPhase 1 / Phase 22026-09-24NCT07734649
Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and OlderHealthy Volunteers; Pandemic Influenza ImmunizationActive, not recruitingPhase 1 / Phase 22026-01-16NCT06907511